September 17, 2014
SAN RAFAEL — MCE Clean Energy, a public, not-for-profit electricity provider that gives customers a choice of having much or all of their electricity supplied from renewable sources such as solar, wind, bioenergy, geothermal and hydroelectric, will move into a new San Rafael office next spring to make way for a growing biopharmaceutical company.
August 1, 2014
NOVATO — A highlight of Friday morning’s ground-breaking ceremony for BioMarin Pharmaceutical’s 85,000-square-foot new research-and-development laboratory at the San Rafael headquarters campus was the emotional testimony of a patient in one of the company’s clinical trials who said the treatment for his rare disease helped him avoid debilitating developmental mental and other conditions.
August 1, 2014
SAN RAFAEL — BioMarin Pharmaceutical, Inc. (Nasdaq: BMRN), is breaking ground on a three-story building at its headquarters campus that will become key to the fast-growing company’s pipeline of treatments for rare diseases and disorders.
July 21, 2014
Santa Rosa Junior College’s (SRJC) Millers Blend olive oil secured a gold medal from Sonoma County Harvest Fair. …
The Olive Press won a Top Ten listing at Terra Olivo, Israel’s international olive oil competition. …
The city of Novato was recognized as a Green Power Community by the U.S. Environmental Protection Agency. …
Sonoma Valley Hospital’s skilled nursing facility was one of only 77 nationally to receive a 2014 Silver Commitment to Quality Award. …
Solage Calistoga was voted among the world’s best resorts by the readers of Travel + Leisure Magazine for the sixth consecutive year. …
LifeGear Design moved to Mare Island in Vallejo from Benicia. …
The Community Child Care Council (4Cs) of Sonoma County received the proceeds from a charity wine dinner at sea. …
Sonoma County received a $471,000 grant for a southwest Santa Rosa park in honor of Andy Lopez. …
BioMarin Pharmaceutical said Health Canada approved its drug Vimizim for Morquio A syndrome. …
Grgich Hills Estate received its second consecutive TripAdvisor Certificate of Excellence award. …
June 16, 2014
NORTH BAY — An ambitious and collaborative effort to lure more life sciences companies to the North Bay will take its message on the road next week, hoping to expand on the success of a growing cluster of pharmaceutical and medical-device companies that bring with them high-paying jobs and an educated workforce.
June 9, 2014
Profiles of 26 human resources executives at top placement agencies or the North Bay’s largest employers.
May 2, 2014
SAN RAFAEL — BioMarin Pharmaceutical, Inc. (Nasdq: BMRN) on Thursday reported an 18.5 percent increase in first-quarter revenue from a year before, and the quarterly net loss improved by 4.3 percent.
April 28, 2014
SAN RAFAEL — BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) on Monday said the European Commission has granted marketing authorization for its treatment of Morquia synrome, a rare inherited metabolic disease.
March 24, 2014
Both San Rafael and Novato experienced increased activity from a leasing and sales perspective for office buildings in 2013 and through the first quarter of this year.
Biotech companies led the sales and leasing charge.
Expect office buildings to sell at the highest pricing levels since 2007.
March 4, 2014
NOVATO — Economic development agencies and life sciences officials across the North Bay are collaborating to draw more biotechnology companies to the region, spurred by recent efforts from the City of Novato and a study by the Marin Economic Forum that found Marin County’s economy has benefited significantly from the industry.
February 26, 2014
SAN RAFAEL — BioMarin Pharmaceutical Inc. (Nasdaq: BRMN) on Wednesday reported its fourth-quarter and full-year net losses expanded nearly 17 percent and 54 percent, respectively, attributed to more research-and-development and marketing expenses for key treatments for rare diseases.
February 24, 2014
SAN RAFAEL — Investors in BioMarin Pharmaceutical (Nasdaq: BRMN) have been bullish about the recent U.S. Food and Drug Administration approval for Vimizim, the first approved treatment for the rare disease Morquio A syndrome.
The price of the company’s stock shot up Thursday and at the close of trading Monday was nearly 7.5 percent higher.
January 13, 2014
Gary Scott, a financial adviser with Edward Jones in Sonoma, and Debbie Gilman and Letizia Veronese, the branch office administrators, were recently honored by the firm for performance and client-service excellence. …
Santa Rosa Breakfast Club recently elected officers for the first half of 2014. …
The city of Fairfield recently hired Bryan Briggs as senior economic development project manager. …
Rebecca Lipski joined Pure Power Solutions in Healdsburg as senior operations manager. …
Tim McDonald, of Cloverdale, was elected chairman of the board of directors at Alexander Valley Healthcare. Joining him on the Executive Committee are Peter Turbott, vice chairman, and Brooke Greene, secretary. Jenine Saunders will continue as treasurer and CFO. …
Community Action Partnership Sonoma County named Tim Reese executive director. …
Marin Humane Society appointed Leilani Borenstein of San Rafael and Chip Smith of Mill Valley to its board of directors. …
Sonoma County radio station KWVF, The Wolf, added radio personality Sue Hall. …
Dana Kreuzberger, broker and manager of the Novato office of Coldwell Banker Residential Brokerage, was named secretary of the Marin County Chapter of the Women’s Council of Realtors. …
The board of directors of BioMarin Pharmaceutical, Inc. promoted Jeff Ajer to executive vice president and chief commercial officer. …
Winegrowers of Dry Creek Valley hired Ann Petersen as the association’s first executive director. …
December 30, 2013
SAN RAFAEL — BioMarin Pharmaceutical, Inc. (Nasdaq: BMRN) made a big signal toward its future plans for its Marin County base of operations when it agreed to pay $116.5 million to purchase the four-building San Rafael Corporate Center complex where the creator of treatments for rare diseases moved its headquarters just over a year ago.
November 7, 2013
NOVATO — Raptor Pharmaceutical Corp (Nasdaq: RPTP) on Thursday reported its third-quarter net loss expanded by nearly 70 percent, attributed to more development dollars poured into its recently approved lead drug.
For the nine months ended in September, Raptor’s net loss was $57.4 million, or $1.01 per share, compared with a net loss of $27.3 million, or $0.56 per share, for the nine-month period ended in August 2012.
September 30, 2013
The San Francisco Bay Regional Water Quality Control Board is is accepting comments on the Renewal of Conditional Waiver of Waste Discharge Requirements for Grazing Operations in the Tomales Bay Watershed. …
Petaluma-based Scott Laboratories announced the release of its first-ever Cider Handbook. …
BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) of San Rafael said it has closed the first patient in the Phase 1/2 trial for BMN 190. …
Ken Frank, executive chef and owner of La Toque restaurant in Napa’s downtown, launched La Toque’s new iPad wine list. …
June 3, 2013
Chicago-based investment adviser Morningstar has increased its fair value estimates for BioMarin Pharmaceutical stock. …
BioCision, a developer of products used to eliminate variability in lab procedures based in Larkspur, recently announced a collaboration with ATCC. …
College of Marin held its annual scholarship awards ceremony, awarding a total of $44,470 to 78 students. …
Marin County’s luxury home market has been churning strongly since the worst of the housing crisis, with the number of sales up 56 percent in April versus the same period in 2012. …
May 9, 2013
SAN RAFAEL — BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) recently reported a net loss of $39.8 million, or 31 cents per share, for the first quarter ended March 31, compared to a net loss of $24 million in the same period last year.
February 21, 2013
SAN RAFAEL — BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) on Thursday reported its fourth-quarter and 2012 net losses about doubled from a year before.
Rumors have been circulating that BioMarin is an acquisition target, but the company CEO fended off that speculation recently.
January 7, 2013
SAN RAFAEL — BioMarin Pharmaceutical Inc. (NASDAQ: BRMN) today said it has acquired San Diego-based Zacharon Pharmaceuticals, a private biotechnology company focused on developing small molecules targeting pathways of glycan and glycolipid metabolism.
- Nov12Registration deadline: November 7, 2014Nov13Registration deadline: November 10, 2014Nov18Registration deadline: November 14, 2014Nov21Registration deadline: November 17, 2014Dec2Registration deadline: November 28, 2014
New NBBJ publication
NBBJ Pulse PollLoading ...
Most popular recent items
- How winery owners can preserve legacy, fairness 8,955 view(s) | posted on September 29, 2014
- 100-plus-employee companies struggle with Obamacare regs 5,754 view(s) | posted on September 29, 2014
- Obama appoints Ebola ‘czar’ to control disease that threatens to overwhelm Africa 5,505 view(s) | posted on October 13, 2014
- Wal-Mart unveils Rohnert Park smaller-format store 4,605 view(s) | posted on September 24, 2014
- Cassidy Turley sees global ties in DTZ purchase 3,453 view(s) | posted on September 29, 2014
Latest reader comments
Business Journal connections